2024
Late Onset of Severe Demyelinating Peripheral Neuropathy in a 62-Year-Old African American Woman
Zivkovic S, DiCapua D. Late Onset of Severe Demyelinating Peripheral Neuropathy in a 62-Year-Old African American Woman. Journal Of Clinical Neuromuscular Disease 2024, 25: 152-156. PMID: 38441936, DOI: 10.1097/cnd.0000000000000481.Peer-Reviewed Original ResearchConceptsAfrican American womenAmerican womenSevere carpal tunnel syndromeCarpal tunnel syndromeHistory of gaitSensorimotor demyelinating polyneuropathyDemyelinating sensorimotor polyneuropathyEarly onset of symptomsSevere demyelinating peripheral neuropathyWalking difficultiesOnset of symptomsFamily historyNatural history studiesCharcot-Marie-Tooth diseaseGenetic testingTunnel syndromeHomozygous pathogenic mutationDistal sensory lossExamination scoresCharcot-Marie-ToothElectrodiagnostic testingDemyelinating polyneuropathySensorimotor polyneuropathySH3TC2 geneUnwitnessed fallNeuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center’s experience
Živković S, Lacomis D, Soman P. Neuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center’s experience. Frontiers In Cardiovascular Medicine 2024, 11: 1345608. PMID: 38410247, PMCID: PMC10894993, DOI: 10.3389/fcvm.2024.1345608.Peer-Reviewed Original ResearchATTRwt patientsPeripheral neuropathyPrevalence of peripheral neuropathySuspected peripheral neuropathyCases of neuropathyDistal sensory lossTransthyretin amyloid depositionCardiomyopathy patientsClinical featuresTransthyretin genotypingMusculoskeletal manifestationsNeuropathy symptomsATTRwtTransthyretin amyloidosisElderly patientsHeart failureTransthyretin mutationFrequent comorbiditiesMultiple potential causesNeuropathySensory lossElderly menPatientsSenile amyloidosisPeripheral nerves
2022
A Second Case of Treatment-resistant CIDP in an IgG Tubulin Autoantibody Positive Patient
Giacobbe A, Al-Lahham T, Ojha A, Zivkovic S. A Second Case of Treatment-resistant CIDP in an IgG Tubulin Autoantibody Positive Patient. RRNMF Neuromuscular Journal 2022, 3: 21-24. DOI: 10.17161/rrnmf.v3i3.17691.Peer-Reviewed Original ResearchSex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Campbell CM, LoRusso S, Dispenzieri A, Kristen AV, Maurer MS, Rapezzi C, Lairez O, Drachman B, Garcia-Pavia P, Grogan M, Chapman D, Amass L, THAOS investigators.. Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Cardiol Ther 2022 PMID: 35583798, DOI: 10.1007/s40119-022-00265-7.Peer-Reviewed Original ResearchNeurologic manifestations of Degos disease (P17-1.003)
Zivkovic S, Al-Lahham T, Lacomis D. Neurologic manifestations of Degos disease (P17-1.003). Neurology 2022, 98 DOI: 10.1212/wnl.98.18_supplement.608.Peer-Reviewed Original ResearchTrends in Diversity at a Single US Adult Neurology Residency Program (P18-13.002)
Fukuda K, Ravishankar M, Van Cott A, Clemens P, Zivkovic S, Ojha A. Trends in Diversity at a Single US Adult Neurology Residency Program (P18-13.002). Neurology 2022, 98 DOI: 10.1212/wnl.98.18_supplement.1957.Peer-Reviewed Original ResearchInternational Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score.
Doets AY, Walgaard C, Lingsma HF, Islam B, Papri N, Yamagishi Y, Kusunoki S, Dimachkie MM, Waheed W, Kolb N, Gorson KC, Jacobs BC, IGOS Consortium.. International Validation of the Erasmus Guillain-Barré Syndrome Respiratory Insufficiency Score. Ann Neurol 2022, 91: 521-531. PMID: 35106830, DOI: 10.1002/ana.26312.Peer-Reviewed Original ResearchA Case of Probable Multifocal Motor Neuropathy With Clinical Stability for Ten Years After a Single Treatment of Rituximab.
Gonzalez NL, Juel VC, Živković SA. A Case of Probable Multifocal Motor Neuropathy With Clinical Stability for Ten Years After a Single Treatment of Rituximab. Journal Of Clinical Neuromuscular Disease 2022, 23: 136-142. PMID: 35188910, DOI: 10.1097/CND.0000000000000358.Peer-Reviewed Original ResearchPredicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score.
Doets AY, Lingsma HF, Walgaard C, Islam B, Papri N, Davidson A, Yamagishi Y, Kusunoki S, Dimachkie MM, Waheed W, Kolb N, Islam Z, Mohammad QD, Harbo T, Sindrup SH, Chavada G, Willison HJ, Casasnovas C, Bateman K, Miller JAL, van den Berg B, Verboon C, Roodbol J, Leonhard SE, Benedetti L, Kuwabara S, Van den Bergh P, Monges S, Marfia GA, Shahrizaila N, Galassi G, Péréon Y, Bürmann J, Kuitwaard K, Kleyweg RP, Marchesoni C, Sedano Tous MJ, Querol L, Illa I, Wang Y, Nobile-Orazio E, Rinaldi S, Schenone A, Pardo J, Vermeij FH, Lehmann HC, Granit V, Cavaletti G, Gutiérrez-Gutiérrez G, Barroso FA, Visser LH, Katzberg HD, Dardiotis E, Attarian S, van der Kooi AJ, Eftimov F, Wirtz PW, Samijn JPA, Gilhuis HJ, Hadden RDM, Holt JKL, Sheikh KA, Karafiath S, Vytopil M, Antonini G, Feasby TE, Faber CG, Gijsbers CJ, Busby M, Roberts RC, Silvestri NJ, Fazio R, van Dijk GW, Garssen MPJ, Straathof CSM, Gorson KC, Jacobs BC, IGOS Consortium.. Predicting Outcome in Guillain-Barré Syndrome: International Validation of the Modified Erasmus GBS Outcome Score. Neurology 2022, 98: e518-e532. PMID: 34937789, DOI: 10.1212/WNL.0000000000013139.Peer-Reviewed Original ResearchElectrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values
Arends S, Drenthen J, van den Bergh P, Franssen H, Hadden R, Islam B, Kuwabara S, Reisin R, Shahrizaila N, Amino H, Antonini G, Attarian S, Balducci C, Barroso F, Bertorini T, Binda D, Brannagan T, Buermann J, Casasnovas C, Cavaletti G, Chao C, Dimachkie M, Fulgenzi E, Galassi G, Gutiérrez G, Harbo T, Hartung H, Hsieh S, Kiers L, Lehmann H, Manganelli F, Marfia G, Mataluni G, Pardo J, Péréon Y, Rajabally Y, Santoro L, Sekiguchi Y, Stein B, Stettner M, Uncini A, Verboon C, Verhamme C, Vytopil M, Waheed W, Wang M, Zivkovic S, Jacobs B, Cornblath D, consortium T, Addington J, Ajroud-Driss S, Andersen H, Antonini G, Attarian S, Badrising U, Balloy G, Barroso F, Bateman K, Bella I, Benedetti L, van den Bergh P, Bertorini T, Bhavaraju-Sanka R, Bianco M, Brannagan T, Briani C, Buerrmann, Busby M, Butterworth S, Casasnovas C, Cavaletti G, Chao C, Chavada G, Chen S, Claeys K, Conti M, Cornblath D, Cosgrove J, Dalakas M, van Damme P, Dardiotis E, Davidson A, Derejko M, van Dijk G, Dimachkie M, van Doorn P, de la Cour C, Echaniz-Laguna A, Eftimov F, Faber C, Fazio R, Feasby T, Fokke C, Fujioka T, Fulgenzi E, Galassi G, Garcia-Sobrino T, Garssen M, Gijsbers C, Gilchrist J, Gilhuis H, Goldstein J, Gorson K, Goyal N, Granit V, Grisanti S, Gutiérrez-Gutiérrez, Gutmann L, Hadden R, Harbo T, Hartung H, Holbech J, Holt J, Hsieh S, Htut M, Hughes R, Illa I, Islam B, Islam Z, Jacobs B, Fehmi J, Jellema K, Pascual I, Kaida K, Karafiath S, Katzberg H, Khoshnoodi M, Kiers L, Kimpinski K, Kleyweg R, Kokubun N, Kolb N, van Koningsveld R, van der Kooi A, Kramers J, Kuitwaard K, Kusunoki S, Kuwabara S, Kwan J, Ladha S, Lassen L, Lawson V, Lehmann H, Pan E, Lunn M, Manji H, Marfia G, Infante C, Martin-Aguilar L, Hernandez E, Mataluni G, Mattiazi M, McDermott C, Meekins G, Miller J, Mohammad Q, Monges M, de la Tassa G, Nascimbene C, Navacerrada-Barrero F, Nobile-Orazio E, Nowak R, Orizaola P, Osei-Bonsu M, Pardal A, Pardo J, Pascuzzi R, Péréon Y, Pulley M, Querol L, Reddel S, van der Ree T, Reisin R, Rinaldi S, Roberts R, Rojas-Marcos I, Rudnicki, Sachs G, Samijn J, Santoro L, Schenone A, Tous M, Shahrizaila N, Sheikh K, Silvestri N, Sindrup S, Sommer C, Stein B, Song Y, Stino A, Tankisi H, Tannemaat M, Twydell P, Vélez-Santamaria P, Varrato J, Vermeij F, Visser L, Vytopil M, Waheed W, Walgaard C, Wang Y, Willison H, Wirtz P, Yamagishi Y, Zhou L, Zivkovic S. Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values. Clinical Neurophysiology 2022, 138: 231-240. PMID: 35078730, DOI: 10.1016/j.clinph.2021.12.014.Peer-Reviewed Original ResearchMuscular Dystrophy
Puwanant A, Zivkovic S, Clemens PR. Muscular Dystrophy. In: Zigmond MJ, Rowlands LP, Coyle JT, editors. Neurobiology of Brain Disorders. (2nd ed). Academic Press, 2022.Chapters
2021
Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
Luijten LWG, Leonhard SE, van der Eijk AA, Doets AY, Appeltshauser L, Arends S, Attarian S, Benedetti L, Briani C, Casasnovas C, Castellani F, Dardiotis E, Echaniz-Laguna A, Garssen MPJ, Harbo T, Huizinga R, Humm AM, Jellema K, van der Kooi AJ, Kuitwaard K, Kuntzer T, Kusunoki S, Lascano AM, Martinez-Hernandez E, Rinaldi S, Samijn JPA, Scheidegger O, Tsouni P, Vicino A, Visser LH, Walgaard C, Wang Y, Wirtz PW, Ripellino P, Jacobs BC, IGOS consortium.. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study. Brain 2021, 144: 3392-3404. PMID: 34553216, DOI: 10.1093/brain/awab279.Peer-Reviewed Original ResearchCharacteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Waddington-Cruz M, Wixner J, Amass L, Kiszko J, Chapman D, Ando Y, THAOS investigators.. Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS). Neurol Ther 2021, 10: 753-766. PMID: 34024024, DOI: 10.1007/s40120-021-00258-z.Peer-Reviewed Original ResearchTemporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey.
Nativi-Nicolau J, Siu A, Dispenzieri A, Maurer MS, Rapezzi C, Kristen AV, Garcia-Pavia P, LoRusso S, Waddington-Cruz M, Lairez O, Witteles R, Chapman D, Amass L, Grogan M, THAOS Investigators.. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey. JACC CardioOncol 2021, 3: 537-546. PMID: 34729526, DOI: 10.1016/j.jaccao.2021.08.009.Peer-Reviewed Original ResearchIntravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study.
Verboon C, Harbo T, Cornblath DR, Hughes RAC, van Doorn PA, Lunn MP, Gorson KC, Barroso F, Kuwabara S, Galassi G, Lehmann HC, Kusunoki S, Reisin RC, Binda D, Cavaletti G, Jacobs BC, IGOS consortium., GOS consortium.. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study. J Neurol Neurosurg Psychiatry 2021, 92: 1080-1088. PMID: 34103340, DOI: 10.1136/jnnp-2020-325815.Peer-Reviewed Original ResearchSex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
Caponetti AG, Rapezzi C, Gagliardi C, Milandri A, Dispenzieri A, Kristen AV, Wixner J, Maurer MS, Garcia-Pavia P, Tournev I, Planté-Bordeneuve V, Chapman D, Amass L, THAOS Investigators.. Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS. JACC Heart Fail 2021, 9: 736-746. PMID: 34391735, DOI: 10.1016/j.jchf.2021.05.005.Peer-Reviewed Original ResearchDoctor—Should I get the COVID‐19 vaccine? Infection and immunization in individuals with neuromuscular disorders
Živković S, Gruener G, Narayanaswami P, Committee T. Doctor—Should I get the COVID‐19 vaccine? Infection and immunization in individuals with neuromuscular disorders. Muscle & Nerve 2021, 63: 294-303. PMID: 33471383, PMCID: PMC8013955, DOI: 10.1002/mus.27179.Peer-Reviewed Original ResearchConceptsEfficacy of immunizationNeuromuscular disordersVaccine-preventable infectionsImmunosuppressive/immunomodulating therapiesImmunocompetent individualsClinical courseCoronavirus disease-2019Reduced immunocompetenceReduced efficacyInfectionCOVID-19 vaccineImmunityVaccination programVaccineCOVID-19EfficacyMolecular and Genetic Therapies.
Narayanaswami P, Živković SA. Molecular and Genetic Therapies. In: Bertorini T, ed. Neuromuscular Disorders. Elsevier, 2021.Chapters
2020
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial
Weiss M, Macklin E, McIlduff C, Vucic S, Wainger B, Kiernan M, Goutman S, Goyal N, Rutkove S, Ladha S, Chen I, Harms M, Brannagan T, Lacomis D, Zivkovic S, Ma M, Wang L, Simmons Z, Rivner M, Shefner J, Cudkowicz M, Atassi N, Group F. Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial. Muscle & Nerve 2020, 63: 371-383. PMID: 33340120, PMCID: PMC8513796, DOI: 10.1002/mus.27146.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAmyotrophic Lateral SclerosisAxonsCortical ExcitabilityDouble-Blind MethodElectrodiagnosisElectromyographyEvoked Potentials, MotorFemaleHumansMaleMedian NerveMexiletineMiddle AgedNeural ConductionPreliminary DataTranscranial Magnetic StimulationVoltage-Gated Sodium Channel BlockersConceptsEffects of mexiletineResting motor thresholdSporadic amyotrophic lateral sclerosisRandomized controlled trialsAxonal hyperexcitabilityAmyotrophic lateral sclerosisRandomized to placeboAxonal excitability studiesCompared to placeboPhase II randomized controlled trialSecondary outcome measuresTranscranial magnetic stimulationPrimary endpointLateral sclerosisAxonal excitabilityHalf-timeTreated subjectsMexiletineReduction of motorControlled trialsHyperexcitabilityALS subjectsAlternative causesMagnetic stimulationOutcome measuresPractical guidance for managing electromyography requests and testing during the COVID-19 pandemic.
Kassardjian CD, Desai U, Narayanaswami P, AANEM Quality and Patient Safety Committee of the AANEM.. Practical guidance for managing electromyography requests and testing during the COVID-19 pandemic. Muscle Nerve 2020, 62: 30-33. PMID: 32277763, DOI: 10.1002/mus.26891.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements